Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00107484 · ClinicalTrials.gov registry record · Phase 2
Magnetic Resonance Imaging Using Ferumoxtran-10 in Finding Metastases to the Axillary Lymph Nodes in Patients With Breast Cancer
A Phase 2 study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT00107484 is a Phase 2 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 3 participants.
The verdict
NCT00107484, a Phase 2 study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures, such as magnetic resonance imaging (MRI) using ferumoxtran-10, may help find and diagnose breast cancer that may have spread to the axillary lymph nodes and may help in planning breast cancer treatment. PURPOSE: This phase II trial is studying how well MRI using ferumoxtran-10 works in finding metastases to the axillary lymph nodes in patients with invasive breast cancer.
Interventions
- PROCEDURE magnetic resonance imaging
- PROCEDURE sentinel lymph node biopsy
- DRUG ferumoxtran-10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2005-09 |
| Est. Completion | 2006-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00107484
The ClinicalTrials.gov registry entry for NCT00107484 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which magnetic resonance imaging is the first listed.
NCT00107484 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00107484 about?
NCT00107484 is a clinical study titled "Magnetic Resonance Imaging Using Ferumoxtran-10 in Finding Metastases to the Axillary Lymph Nodes in Patients With Breast Cancer". RATIONALE: Diagnostic procedures, such as magnetic resonance imaging (MRI) using ferumoxtran-10, may help find and diagnose breast cancer that may have spread to the axillary lymph nodes and may help in planning breast cancer treatment. PURPOSE: This phase II trial is studying how well MRI using fe...
What is the current status of trial NCT00107484?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2005-09. Estimated completion is 2006-10.
What interventions are being tested in trial NCT00107484?
The interventions under investigation include: magnetic resonance imaging (PROCEDURE), sentinel lymph node biopsy (PROCEDURE), ferumoxtran-10 (DRUG).
Who is sponsoring clinical trial NCT00107484?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.